Vivoryon Therapeutics NV
AEX:VVY

Watchlist Manager
Vivoryon Therapeutics NV Logo
Vivoryon Therapeutics NV
AEX:VVY
Watchlist
Price: 1.67 EUR -0.24%
Market Cap: 43.8m EUR

Wall Street
Price Targets

VVY Price Targets Summary
Vivoryon Therapeutics NV

Wall Street analysts forecast VVY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VVY is 5.23 EUR with a low forecast of 2.02 EUR and a high forecast of 8.93 EUR.

Lowest
Price Target
2.02 EUR
21% Upside
Average
Price Target
5.23 EUR
213% Upside
Highest
Price Target
8.93 EUR
434% Upside
Vivoryon Therapeutics NV Competitors:
Price Targets
GLUE
Monte Rosa Therapeutics Inc
154% Upside
ALT
Altimmune Inc
375% Upside
2142
Hbm Holdings Ltd
10% Downside
AMGN
Amgen Inc
12% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
27% Upside
ZNTL
Zentalis Pharmaceuticals Inc
315% Upside
2616
CStone Pharmaceuticals
25% Downside
PEB
Pacific Edge Ltd
24% Downside

Revenue
Forecast

Revenue Estimate
Vivoryon Therapeutics NV

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Vivoryon Therapeutics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
Vivoryon Therapeutics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-46%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VVY's stock price target?
Price Target
5.23 EUR

According to Wall Street analysts, the average 1-year price target for VVY is 5.23 EUR with a low forecast of 2.02 EUR and a high forecast of 8.93 EUR.

Back to Top